Literature DB >> 2816927

Clearance of polymeric IgA aggregates in humans.

D Roccatello1, G Picciotto, R Coppo, G Piccoli, A Molino, G Cacace, A Amore, A Amoroso, G Quattrocchio, L M Sena.   

Abstract

Clearance of aggregated human secretory immunoglobulin A (AHS-IgA) was studied in nine patients affected by primary IgA nephropathy (IgAGN) and six normal volunteers from the medical staff. Samples of whole blood, erythrocytes, and serum were taken from 3 to 120 minutes after injection of 0.5 mg of 131iodine-labeled AHS-IgA. No significant radioactivity was recorded on erythrocytes. The clearance curve of AHS-IgA from the circulation, calculated by measuring trichloroacetic acid precipitable radioactivity in serum, was found to be biexponential with an initial fast component significantly prolonged in patients (mean half-time, 19.4 minutes, range, 14 to 26 minutes) compared with controls (mean, 12.2 minutes, range, 7.6 to 16.8 minutes; P less than 0.01). These data indicate that clearance of aggregated polymeric IgA does not involve the erythrocyte transport system and seems to be defective in IgAGN patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816927     DOI: 10.1016/s0272-6386(89)80167-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

Review 1.  Immunopathogenesis of experimental IgA nephropathy.

Authors:  A Rifai
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Kupffer cell depletion in vivo results in clearance of large-sized IgA aggregates in rats by liver endothelial cells.

Authors:  W M Bogers; R K Stad; D J Janssen; F A Prins; N van Rooijen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells.

Authors:  T J Reterink; W E Schroeijers; L A Es; M R Daha
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.